Sort by

Send to:

Choose Destination

Search results

Items: 5


Whole genome sequencing as a diagnostic test: challenges and opportunities.

Chrystoja CC, Diamandis EP.

Clin Chem. 2014 May;60(5):724-33. doi: 10.1373/clinchem.2013.209213. Epub 2013 Nov 13. Review.


False biomarker discovery due to reactivity of a commercial ELISA for CUZD1 with cancer antigen CA125.

Prassas I, Brinc D, Farkona S, Leung F, Dimitromanolakis A, Chrystoja CC, Brand R, Kulasingam V, Blasutig IM, Diamandis EP.

Clin Chem. 2014 Feb;60(2):381-8. doi: 10.1373/clinchem.2013.215236. Epub 2013 Oct 4.


Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues.

Kosanam H, Prassas I, Chrystoja CC, Soleas I, Chan A, Dimitromanolakis A, Blasutig IM, Rückert F, Gruetzmann R, Pilarsky C, Maekawa M, Brand R, Diamandis EP.

Mol Cell Proteomics. 2013 Oct;12(10):2820-32. doi: 10.1074/mcp.M112.023507. Epub 2013 Jun 24.


Pancreatic cancer.

Chrystoja CC, Diamandis EP, Brand R, Rückert F, Haun R, Molina R.

Clin Chem. 2013 Jan;59(1):41-6. doi: 10.1373/clinchem.2012.196642. Epub 2012 Nov 7. No abstract available.


Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery.

Prassas I, Chrystoja CC, Makawita S, Diamandis EP.

BMC Med. 2012 Apr 19;10:39. doi: 10.1186/1741-7015-10-39.

Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk